Oral Cancer Awareness Month

Cancer stem cell types predict outcome of HPV-related HNC

Share This Post

By Donna Domino, Features Editor
Dr. Bicuspid

February 10, 2014 — The type of cancer stem cells, rather than the number, is a better predictor of the survival of patients with human papillomavirus (HPV)-related head and neck cancer, according to a new study in Cancer (December 30, 2013). Previously, researchers thought patients with HPV-positive tumors had better outcomes because their tumors had fewer cancer stem cells than HPV-negative tumors. Ohio researchers discovered just the opposite, however.

Read complete article about cancer stem cell types, including details of the retrospective study by researchers from Ohio State University at Dr.Bicuspid

author avatar
Erron S Brady

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

What is Adjunctive Oral Cancer Screening?

Adjunctive oral cancer screening technologies are used in conjunction with the COE to help detect abnormalities and provide additional information to be utilized in the clinical decision-making process.

Do You Want To Boost Your Business?

drop us a line and keep in touch